Pura Vida Investments, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Pura Vida Investments, LLC reported 16 stock positions worth $60.8 million. Its top holding was Advisorshares Pure US Cann (MSOS) at 19.1% of the portfolio, followed by Establishment Labs (ESTA, 13.7%) and Glaukos (GKOS, 9.4%). Compared with Q2 2024, it sold out of 9, added to 2 and reduced 11. The biggest buy was Advisorshares Pure US Cann (MSOS, shares +106%) and the biggest sale an exit from Livanova (LIVN).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001590144
- Portfolio Value
- $60.8M (Q3 2024)
- SEC Filing
- 0001590144-24-000023 ↗ filed Nov 14, 2024
Holdings Value
Holdings 16 stocks · $60.8M
| MSOS Advisorshares Pure US Cann | 19.13% | 1,623,100 | $11.6M | Add +106.2% |
| ESTA Establishment Labs Holdings | 13.66% | 191,939 | $8.3M | Reduce -16.6% |
| GKOS Glaukos Corp. | 9.43% | 44,000 | $5.7M | Reduce -49.4% |
| NTRA Natera Inc. | 9.08% | 43,500 | $5.5M | Reduce -35.6% |
| ISRG Intuitive Surgical Inc. | 8.24% | 10,200 | $5.0M | Reduce -46.0% |
| QTRX Quanterix Corp. | 7.47% | 350,701 | $4.5M | Reduce -14.3% |
| LUNG Pulmonx Corp. | 6.95% | 509,775 | $4.2M | Reduce -0.6% |
| BVS Bioventus Inc. Class A | 6.93% | 352,569 | $4.2M | Add +25.9% |
| ICUI Icu Medical Inc. | 6.74% | 22,500 | $4.1M | Reduce -23.3% |
| CSTL Castle Biosciences Inc. | 2.95% | 62,868 | $1.8M | Reduce -59.0% |
| IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP | 2.32% | 495,345 | $1.4M | No change |
| BRKR Bruker Corp. | 2.04% | 18,000 | $1.2M | Reduce -44.6% |
| NSPR Inspiremd Inc. | 1.99% | 450,517 | $1.2M | No change |
| CUTRQ Cutera Inc. | 1.51% | 1,165,497 | $919K | Reduce -0.0% |
| MGX Metagenomi Therapeutics Inc. | 0.97% | 270,618 | $587K | No change |
| ZIMV Zimvie Inc. | 0.60% | 23,000 | $365K | Reduce -67.1% |
Options reported separately and not counted above: IHI puts ($8.9M), IWM puts ($8.8M), SPY puts ($8.6M), QQQ puts ($7.3M), COO calls ($6.6M), INSP calls ($6.3M), WAT puts ($6.3M), XBI puts ($4.9M), ZBH puts ($4.9M), ZTS puts ($3.9M), MDT puts ($3.6M), SYK puts ($3.3M), and 12 more.
Other holdings (2): bonds, preferreds, convertibles and warrants · $20K (not counted above)
Total filed on the 13F, all lines: $60.8M.
Portfolio Sells Q2 2024 → Q3 2024
| LIVN Livanova PLC | Sold out | 0.00% | −5.19 |
| MASI Masimo Corp. | Sold out | 0.00% | −3.81 |
| GKOS Glaukos Corp. | Reduce -49.4% | 9.43% | −3.02 |
| ATEC Alphatec Holdings Inc. | Sold out | 0.00% | −2.51 |
| TNDM Tandem Diabetes Care Inc. | Sold out | 0.00% | −1.97 |
| ISRG Intuitive Surgical Inc. | Reduce -46.0% | 8.24% | −1.93 |
| STAA Staar Surgical Co. | Sold out | 0.00% | −1.73 |
| CSTL Castle Biosciences Inc. | Reduce -59.0% | 2.95% | −1.09 |
| ELAN Elanco Animal Health Inc. | Sold out | 0.00% | −0.99 |
| ZIMV Zimvie Inc. | Reduce -67.1% | 0.60% | −0.94 |
| CUTRQ Cutera Inc. | Reduce -0.0% | 1.51% | −0.62 |
| TWST Twist Bioscience Corp. | Sold out | 0.00% | −0.60 |
| NARI Inari Medical Inc. | Sold out | 0.00% | −0.58 |
| BRKR Bruker Corp. | Reduce -44.6% | 2.04% | −0.46 |
| WGS Genedx Holdings Corp. | Sold out | 0.00% | −0.32 |
| NTRA Natera Inc. | Reduce -35.6% | 9.08% | +0.24 |
| QTRX Quanterix Corp. | Reduce -14.3% | 7.47% | +0.93 |
| ESTA Establishment Labs Holdings | Reduce -16.6% | 13.66% | +1.01 |
| ICUI Icu Medical Inc. | Reduce -23.3% | 6.74% | +2.53 |
| LUNG Pulmonx Corp. | Reduce -0.6% | 6.95% | +3.02 |
Portfolio Buys Q2 2024 → Q3 2024
Options Activity Q2 2024 → Q3 2024
| IHI iShares U.S. Medical Devices | put | New | 150,000 | $8.9M |
| IWM iShares Russell 2000 ETF | put | New | 40,000 | $8.8M |
| SPY SS SPDR S&P 500 ETF Trust-US | put | Reduce -40.0% | 15,000 | $8.6M |
| QQQ Invesco QQQ Trust Series 1 | put | Reduce -25.0% | 15,000 | $7.3M |
| COO The Cooper Cos Inc. | call | Add +100.0% | 60,000 | $6.6M |
| INSP Inspire Medical Systems Inc. | call | New | 30,000 | $6.3M |
| WAT Waters Corp. | put | New | 17,500 | $6.3M |
| MASI Masimo Corp. | call | Sold out | 44,500 | $5.6Mbefore exit |
| ACWX iShares MSCI Acwi Ex US ETF | put | Sold out | 90,000 | $5.0Mbefore exit |
| XBI SS SPDR S&P Biotech ETF | put | New | 50,000 | $4.9M |
| ZBH Zimmer Biomet Holdings Inc. | put | New | 45,000 | $4.9M |
| XITK SS SPDR F Inno Tech ETF | put | Sold out | 50,000 | $4.6Mbefore exit |
| RMD Resmed Inc. | put | Sold out | 24,000 | $4.6Mbefore exit |
| IXP iShares Global Comm Services | put | Sold out | 20,000 | $4.1Mbefore exit |
| INSP Inspire Medical Systems Inc. | put | Sold out | 30,000 | $4.0Mbefore exit |
| ZTS Zoetis Inc. | put | New | 20,000 | $3.9M |
| MDT Medtronic PLC | put | Add +33.3% | 40,000 | $3.6M |
| SYK Stryker Corp. | put | New | 9,000 | $3.3M |
| GH Guardant Health Inc. | call | Sold out | 100,000 | $2.9Mbefore exit |
| ICUI Icu Medical Inc. | call | New | 15,000 | $2.7M |
| LLY Eli Lilly & Co. | put | New | 3,000 | $2.7M |
| GH Guardant Health Inc. | put | New | 115,000 | $2.6M |
| LIVN Livanova PLC | call | Sold out | 46,700 | $2.6Mbefore exit |
| ARKK ARK Innovation ETF | put | Sold out | 50,000 | $2.2Mbefore exit |
| PRCT Procept Biorobotics Corp. | put | New | 25,000 | $2.0M |
| ARKG ARK Genomic Revolution ETF | put | Reduce -34.8% | 75,000 | $1.9M |
| DHR Danaher Corp. | put | Sold out | 7,500 | $1.9Mbefore exit |
| ELAN Elanco Animal Health Inc. | call | New | 100,000 | $1.5M |
| STAA Staar Surgical Co. | call | Sold out | 30,000 | $1.4Mbefore exit |
| CSTL Castle Biosciences Inc. | call | New | 50,000 | $1.4M |
| TNDM Tandem Diabetes Care Inc. | call | New | 30,000 | $1.3M |
| BAX Baxter International Inc. | call | New | 30,000 | $1.1M |
| SOLV Solventum Corp. | put | Sold out | 21,000 | $1.1Mbefore exit |
| STE Steris PLC | put | Sold out | 5,000 | $1.1Mbefore exit |
| PEN Penumbra Inc. | put | Sold out | 6,000 | $1.1Mbefore exit |
| GEHC GE Healthcare Technology | put | Sold out | 10,000 | $779Kbefore exit |
| MMM 3M Co. | call | New | 4,000 | $547K |
| ENOV Enovis Corp. | put | Sold out | 8,000 | $362Kbefore exit |
| DCGO Docgo Inc. | put | New | 100,000 | $332K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $37.0M | ALMR, BBNX, ESTA, IMDX, NVDA |
| Q1 2026 | 17 | $14.9M | IMDX, BBNX, ESTA, CAI, NSPR |
| Q4 2025 | 18 | $26.8M | BBNX, IMDX, ESTA, CAI, NSPR |
| Q3 2025 | 8 | $16.4M | BBNX, IMDX, CAI, ESTA, NSPR |
| Q2 2025 | 8 | $16.6M | BBNX, IMDX, CAI, ESTA, OM |
| Q1 2025 | 8 | $13.7M | BBNX, IMDX, ESTA, NSPR, KMTS |
| Q4 2024 | 9 | $18.1M | ESTA, MSOS, LUNG, QTRX, IMDX |
| Q3 2024 | 16 | $60.8M | MSOS, ESTA, GKOS, NTRA, ISRG |
| Q2 2024 | 25 | $82.7M | ESTA, GKOS, ISRG, NTRA, MSOS |
| Q1 2024 | 30 | $146.8M | EXAS, ESTA, ISRG, QTRX, LYRA |